LONDON BROKER RATINGS: Exane BNP and HSBC cut BP; JPM likes Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

----------

FTSE 100

----------

Exane BNP cuts BP to 'neutral' (outperform) - price target 465 pence

----------

HSBC cuts BP to 'reduce' - price target 430 pence

----------

UBS cuts BP price target to 455 (465) pence - 'neutral'

----------

Goldman Sachs raises AstraZeneca price target to 16,496 (16,389) pence - 'buy'

----------

LBBW raises AstraZeneca price target to 16,000 (14,000) pence - 'buy'

----------

JPMorgan raises Barclays price target to 590 (570) pence - 'overweight'

----------

JPMorgan cuts NatWest price target to 730 (750) pence - 'overweight'

----------

RBC cuts Barratt Redrow price target to 425 (450) pence - 'sector perform'

----------

FTSE 250

----------

Panmure Liberum raises Ashmore Group price target to 350 (240) pence - 'buy'

----------

JPMorgan reinitiates Unite Group with 'overweight' - price target 725 pence

----------

Jefferies cuts HgCapital Trust to 'underperform' (hold)

----------

SMALL CAP

----------

Goldman Sachs cuts Flutter Entertainment price target to 19,700 (22,300) pence - 'buy'

----------

JPMorgan raises Smurfit Westrock target to 5,000 (4,300) pence - 'overweight'

----------

RBC cuts MJ Gleeson price target to 375 (400) pence - 'underperform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

MJGleeson

Smurfit West

Flutter Entertainment

HgCapital Trust plc

Unite

Ashmore Group

Barratt Redrow

Natwest

Barclays

Astrazeneca

BP